Takeda-Led COVID-19 Plasma Product to Begin Trial This Month Takeda-Led COVID-19 Plasma Product to Begin Trial This Month

An experimental COVID-19 therapy using blood plasma, developed by Japan ' s Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news